This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Ono Pharmaceutical Co., Ltd., Tokushima University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 575 
1 out of 42 
Years Active: 2025
Title: Takeo Maeda: Innovator in Immunosuppressive Agents
Introduction
Takeo Maeda is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on immunosuppressive agents. His research has the potential to impact various medical treatments and therapies.
Latest Patents
Takeo Maeda holds 1 patent for an immunosuppressive agent. This agent contains a substance selected from anti-CD80 antibodies and anti-PD-L1 antibodies, which promotes binding between PD-L1 and PD-1. This innovation is crucial for advancing treatments in immunology.
Career Highlights
Throughout his career, Takeo Maeda has worked with prominent organizations, including Ono Pharmaceutical Co., Ltd. and Tokushima University. His experience in these institutions has allowed him to develop and refine his research in immunosuppressive therapies.
Collaborations
Takeo Maeda has collaborated with notable colleagues such as Taku Okazaki and Daisuke Sugiura. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field.
Conclusion
Takeo Maeda's work in immunosuppressive agents showcases his dedication to advancing medical science. His contributions are significant and reflect the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile